Avion Wealth’s Immunovant IMVT Stock Holding History

Avion Wealth’s Portfolio IMVT Stock Details IMVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$0	Hold	29	–	–	﹤0.01%	1418
2025 Q4	$0	Hold	29	–	–	﹤0.01%	1405
2025 Q3	$0	Buy	+29	New	+$469	﹤0.01%	1371

Other funds holding IMVT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Avion Wealth's IMVT Position: Q1 2026 in Review

Avion Wealth held its Immunovant (IMVT) position steady in Q1 2026 at 29 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #1418.

Avion Wealth first reported a position in IMVT in Q3 2025 and has held it in 3 quarters since. 215 funds tracked by Wall St. Rank hold IMVT as of Q1 2026.

Avion Wealth held 29 shares of Immunovant worth $0 as of Q1 2026.
Avion Wealth left its Immunovant share count unchanged in Q1 2026.
Immunovant made up ﹤0.01% of Avion Wealth's portfolio in Q1 2026, its #1418 holding.
Avion Wealth first reported a position in Immunovant in Q3 2025 and has held it in 3 quarters since.
215 funds tracked by Wall St. Rank held Immunovant as of Q1 2026.

Based on Avion Wealth's 13F filing for Q1 2026, filed 1 May 2026.